Status:
COMPLETED
Detection of Pulmonary Embolism With CECT
Lead Sponsor:
Bracco Diagnostics, Inc
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
Eligibility Criteria
Inclusion
- Patients 18 yrs or older
- With suspected PE
- Referred for MDCTA of pulmonary arteries
- Signed informed consent
Exclusion
- Pregnant and lactating females
- History of hypersensitivity to iodinated contrast agents
- Hyperthyroidism or pheochromocytoma
- Severe CHF
- Renal impairment
- Weight greater than 300 lbs
- Pacemaker
- Swan Ganz catheter
- Defibrillator or other intrathoracic metallic vascular device
- Received an investigational compound within 30 days of being in the study
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00351754
Start Date
July 1 2006
End Date
November 1 2006
Last Update
January 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bracco Diagnostics, Inc.
Princeton, New Jersey, United States, 08540